MoonLake Immunotherapeutics
MLTX
#3397
Rank
โ‚ฌ3.17 B
Marketcap
50,33ย โ‚ฌ
Share price
0.56%
Change (1 day)
-5.48%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -โ‚ฌ99.07 Million

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ52.22 Million, an increase over its 2022 earnings that were of -โ‚ฌ62.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ99.07 Million89.73%
2023 -โ‚ฌ52.22 Million-16.81%
2022 -โ‚ฌ62.78 Million